锦欣生殖医疗集团有限公司（股票代码：01951）于2026年4月30日公告，近日在香港联交所场内进行股份回购，并披露已发行股本变动情况。
公告显示，当日公司合计回购2,000,000股，占已发行股本约0.07%，回购价格区间介乎每股2.39港元至2.40港元，合计付出约4,783,000港元，折合约478.30万港元。公司提及本次回购股份暂未被注销，截至2026年4月30日已发行股本约2,705,044,043股，库存股数量为0股。
购回授权于2025年6月26日获得通过，授权购回股份总数为274,470,604股。自获授权以来，公司已合并回购59,328,000股，占授权通过当日已发行股本总数的2.1615%。公司表示，此次回购活动符合香港联交所证券上市规则的相关规定，且相关声明文件并无重大变动。
本公告由公司董事董阳签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.